Total submissions: 8
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000766292 | SCV000239003 | uncertain significance | not provided | 2018-04-16 | criteria provided, single submitter | clinical testing | p.Arg1027Trp (CGG>TGG): c.3079 C>T in exon 29 in the MTR gene (NM_000254.2). The R1027W variant in the MTR gene has not been published as a pathogenic variant, nor has it been reported as a benign polymorphism to our knowledge. The NHLBI ESP Exome Sequencing Project reports R1027W was observed in 33/8600 alleles (0.38%) from individuals of European American background; however, this variant was not observed in the homozygous state in any individual within this population. The R1027W variant is a non-conservative amino acid substitution, which is likely to impact secondary protein structure as these residues differ in polarity, charge, size and/or other properties. This substitution occurs at a position that is not conserved across species. In silico analysis is inconsistent in its predictions as to whether or not the variant is damaging to the protein structure/function. We interpret R1027W as a variant of unknown significance. This variant has been observed to be maternally and paternally inherited. The variant is found in the MTR panel. |
Illumina Laboratory Services, |
RCV000314594 | SCV000356047 | likely benign | Disorders of Intracellular Cobalamin Metabolism | 2018-01-12 | criteria provided, single submitter | clinical testing | This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as likely benign is not then subjected to further curation. The score for this variant resulted in a classification of likely benign for this disease. |
ARUP Laboratories, |
RCV000766292 | SCV000604297 | uncertain significance | not provided | 2019-11-03 | criteria provided, single submitter | clinical testing | The MTR c.3079C>T, p.Arg1027Trp variant (rs116836001), to our knowledge, is not reported in the medical literature but is reported in ClinVar (Variation ID: 203839). This variant is found in the general population with an allele frequency of 0.28% (811/282,858 alleles, including 6 homozygotes) in the Genome Aggregation Database. The arginine at codon 1027 is weakly conserved, and computational analyses (SIFT: damaging, PolyPhen-2: benign) predict conflicting effects of this variant on protein structure/function. Due to limited information, the clinical significance of this variant is uncertain at this time. |
Invitae | RCV001080972 | SCV001115736 | benign | Methylcobalamin deficiency type cblG | 2024-01-29 | criteria provided, single submitter | clinical testing | |
Ce |
RCV000766292 | SCV004009948 | likely benign | not provided | 2023-06-01 | criteria provided, single submitter | clinical testing | MTR: BP4, BS2 |
Prevention |
RCV003927726 | SCV004742065 | likely benign | MTR-related disorder | 2024-02-15 | criteria provided, single submitter | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |
Genome Diagnostics Laboratory, |
RCV000766292 | SCV001978147 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV000766292 | SCV001980285 | likely benign | not provided | no assertion criteria provided | clinical testing |